- +220.0% price growth over the last year
- Bullish trend confirmed on both short and long timeframes
- Consistently positive technical signals over the last month
Red day on Monday for Esperion Therapeutics
(Updated on Jun 29, 2026)
The Esperion Therapeutics stock price fell by -0.631% on the last day (Monday, 29th Jun 2026) from $3.17 to $3.15. During the last trading day the stock fluctuated 0.635% from a day low at $3.15 to a day high of $3.17. The price has risen in 4 of the last 10 days. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -8 million shares and in total, 6 million shares were bought and sold for approximately $18.02 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 50.97% during the next 3 months and, with a 90% probability hold a price between $4.22 and $5.44 at the end of this 3-month period.
ESPR Signals & Forecast
The Esperion Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.16. On a fall, the stock will find some support from the long-term average at approximately $3.14. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -0.631%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Esperion Therapeutics stock
Esperion Therapeutics finds support from accumulated volume at $3.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0200 between high and low, or 0.635%. For the last week the stock has had daily average volatility of 0.636%.
Our recommended stop-loss: $3.02 (-4.24%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (ESPR) For The Upcoming Trading Day Of Tuesday 30th
For the upcoming trading day on Tuesday, 30th we expect Esperion Therapeutics to open at $3.16, and during the day (based on 14 day Average True Range), to move between $3.14 and $3.16, which gives a possible trading interval of +/-$0.0291 (+/-0.93%) up or down from last closing price. If Esperion Therapeutics takes out the full calculated possible swing range there will be an estimated 0.93% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $3.16 (0.32%) than the support at $3.13 (0.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Esperion Therapeutics stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Esperion Therapeutics stock to perform well in the short-term.
Current score:
2.809
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 30, 2026 - $3.16 ( 0.212%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ESPR Performance
Trading levels for ESPR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.18 | 0.85% |
| R2 | 3.17 | 0.604% |
| R1 | 3.16 | 0.454% |
| Price | 3.15 | |
| S1 | 3.15 | -0.0309% |
| S2 | 3.14 | -0.181% |
| S3 | 3.14 | -0.423% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 3.17 | 0.635% |
| R1 | 3.16 | 0.317% |
| Price | 3.15 | |
| S1 | 3.13 | -0.635% |
| S2 | 3.12 | -0.95% |
| S3 | 3.11 | -1.27% |
FAQ
Click here for our free guide on how to buy Esperion Therapeutics Stock.
Buy ESPR